Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$899K Sell
7,476
-60
-0.8% -$6.93K 0.27% 48
2025
Q4
$793K Sell
7,536
-42
-0.6% -$3.94K 0.24% 50
2025
Q3
$636K Hold
7,578
0.2% 54
2025
Q2
$600K Hold
7,578
0.2% 55
2025
Q1
$680K Sell
7,578
-65
-0.9% -$6.07K 0.24% 50
2024
Q4
$760K Hold
7,643
0.27% 48
2024
Q3
$868K Hold
7,643
0.3% 44
2024
Q2
$946K Hold
7,643
0.35% 43
2024
Q1
$1.01M Hold
7,643
0.38% 42
2023
Q4
$833K Hold
7,643
0.33% 42
2023
Q3
$787K Hold
7,643
0.34% 45
2023
Q2
$882K Sell
7,643
-25
-0.3% -$2.84K 0.36% 44
2023
Q1
$816K Hold
7,668
0.34% 43
2022
Q4
$851K Hold
7,668
0.36% 41
2022
Q3
$660K Buy
7,668
+46
+0.6% +$4.11K 0.29% 47
2022
Q2
$695K Buy
7,622
+58
+0.8% +$5.14K 0.29% 44
2022
Q1
$621K Hold
7,564
0.22% 53
2021
Q4
$580K Hold
7,564
0.2% 49
2021
Q3
$568K Sell
7,564
-12
-0.2% -$913 0.2% 47
2021
Q2
$589K Sell
7,576
-351
-4% -$26.1K 0.22% 43
2021
Q1
$583K Buy
7,927
+20
+0.3% +$1.48K 0.24% 41
2020
Q4
$617K Buy
+7,907
New +$605K 0.28% 38

Other funds holding MRK

Red Wave Investments's MRK Position: Q1 2026 in Review

Red Wave Investments reduced its Merck (MRK) stake by 0.8% in Q1 2026, selling an estimated $6.93K and leaving 7,476 shares worth $899K. The position accounts for 0.27% of the portfolio, ranked #48.

Red Wave Investments first reported a position in MRK in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.01M in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Red Wave Investments held 7,476 shares of Merck worth $899K as of Q1 2026.
  • Red Wave Investments sold 60 Merck shares in Q1 2026, an estimated $6.93K.
  • Merck made up 0.27% of Red Wave Investments's portfolio in Q1 2026, its #48 holding.
  • Red Wave Investments first reported a position in Merck in Q4 2020 and has held it in 22 quarters since.
  • Red Wave Investments's Merck position peaked at $1.01M in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Red Wave Investments's 13F filing for Q1 2026, filed 8 May 2026.